HUMDF (Hua Medicine) Owner Earnings per Share (TTM): 0.17 (As of Dec. 2025) — 89% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HUMDF Hua Medicine HUMDF
44 GF Score
Price $0.31
GF Value $1.18
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Hua Medicine Owner Earnings per Share (TTM)?

Hua Medicine HUMDF 44 Owner Earnings per Share (TTM) is 0.17 as of Dec. 2025, which is 89% below its 10-year median of 1.56. GuruFocus rates HUMDF with a GF Score™ of 44/100 and a GF Value™ of $1.18 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 474 Drug Manufacturers companies, Hua Medicine ranks better than 98.52% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Hua Medicine's Owner Earnings per Share (TTM) ended in Dec. 2025 was $0.17. It's Price-to-Owner-Earnings ratio for today is 1.85.


The historical rank and industry rank for Hua Medicine's Owner Earnings per Share (TTM) or its related term are showing as below:

HUMDF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 1.11   Med: 1.56   Max: 2.95
Current: 1.83


During the past 10 years, the highest Price-to-Owner-Earnings ratio of Hua Medicine was 2.95. The lowest was 1.11. And the median was 1.56.


HUMDF's Price-to-Owner-Earnings is ranked better than
98.52% of 474 companies
in the Drug Manufacturers industry
Industry Median: 23.28 vs HUMDF: 1.83

Hua Medicine's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $-0.01. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.15. It's PE Ratio (TTM) ratio for today is 2.05.

Hua Medicine's EPS without NRI for the six months ended in Dec. 2025 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.02. It's PE Ratio without NRI ratio for today is At Loss.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Hua Medicine Owner Earnings per Share (TTM) Related Terms


Hua Medicine Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Hua Medicine's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hua Medicine Owner Earnings per Share (TTM) Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.03 0.11 -0.04 0.17

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.00 -0.04 0.00 0.17

HUMDF vs ZTS: Owner Earnings per Share (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hua Medicine Price-to-Owner-Earnings vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Hua Medicine's Price-to-Owner-Earnings falls into.


HUMDF
44GF Score
Hua Medicine HUMDF
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hua Medicine Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Hua Medicine's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 157.08
Depreciation, Depletion and Amortization 4.61
Change In Deferred Tax 0.00
5Y Average of Maintenance Capital Expenditure 3.48
Change In Working Capital 5.94
Shares Outstanding (Diluted Average) 1,005.78

1. Start with "Net Income" from income statement. Hua Medicine's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was $157.08 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Hua Medicine's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was $4.61 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Hua Medicine's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $3.48 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Hua Medicine's 5-Year Average Maintenance Capital Expenditure = $3.48 Mil

5. "Change In Working Capital" is from cashflow statement. Hua Medicine's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was $5.94 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Hua Medicine's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 1005.775 Mil.

Hua Medicine's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 157.081 +4.61+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-3.484+5.939)/1005.775
=0.17

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=0.31435/0.17
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 0.17 mean?
Hua Medicine (HUMDF) has a Owner Earnings per Share (TTM) of 0.17 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Hua Medicine. This is 89% below median its historical median of 1.56. Over the past decade, Hua Medicine's Owner Earnings per Share (TTM) has ranged from 1.11 to 2.95. According to the industry distribution chart, Hua Medicine ranks #7 out of 474 companies in the Drug Manufacturers industry, placing it in the top 1.5%.
Is Hua Medicine's Owner Earnings per Share (TTM) too high?
Hua Medicine's current Owner Earnings per Share (TTM) of 0.17 is 89% below median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 2.95. The Drug Manufacturers industry median Owner Earnings per Share (TTM) is 23.28. Hua Medicine's value of 0.17 is 99.3% below this industry median. Based on the distribution chart, Hua Medicine ranks #7 out of 474 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hua Medicine has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hua Medicine's Owner Earnings per Share (TTM) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hua Medicine ranks #7 out of 474 companies for Owner Earnings per Share (TTM). This places Hua Medicine in the top 2% of its industry — outperforming the majority of peers. The industry median Owner Earnings per Share (TTM) is 23.28. Hua Medicine's value of 0.17 is 99.3% below this benchmark. Historically, Hua Medicine's own Owner Earnings per Share (TTM) has ranged from 1.11 to 2.95 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 23.28, Hua Medicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Drug Manufacturers company?
The median Owner Earnings per Share (TTM) among Drug Manufacturers companies is 23.28, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hua Medicine's current Owner Earnings per Share (TTM) of 0.17 is 99.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Hua Medicine. For the Drug Manufacturers industry, the median Owner Earnings per Share (TTM) is 23.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hua Medicine's current Owner Earnings per Share (TTM) is 0.17, which is 89% below median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hua Medicine stock overvalued right now?
Based on GuruFocus' analysis, Hua Medicine (HUMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.18, compared to a current price of $0.31 — trading 73.4% below its estimated fair value. The current Owner Earnings per Share (TTM) is 0.17, which is 89% below median its 10-year median of 1.56 and 99.3% below the Drug Manufacturers industry median of 23.28. Hua Medicine's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Hua Medicine (HUMDF), the current Owner Earnings per Share (TTM) is 0.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hua Medicine (HUMDF) Overvalued in 2026?

Based on GuruFocus' analysis, Hua Medicine stock appears to be undervalued. The current stock price of $0.31 is trading 73.4% below its estimated GF Value™ of $1.18. GuruFocus considers Hua Medicine to be Possible Value Trap.

Key valuation signals for HUMDF:

  • Owner Earnings per Share (TTM): 0.17 (89% below median its 10-year median of 1.56)
  • GF Value™: $1.18 vs. price of $0.31 (73.4% below fair value)
  • GF Score™: 44/100 with 6 warning signs
  • Industry Position: 99.3% below the Drug Manufacturers median (#7 of 474)

No single metric tells the full story. See the HUMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hua Medicine Business Description

Other Exchanges 02552:Hong Kong
Address Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin (HMS5552), for the treatment of Type 2 diabetes. Dorzagliatin is a first-in-class glucokinase activator, or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The group majorly operates and generates the majority of its revenue from the PRC.
44GF Score

Get the complete analysis for HUMDF

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price
$1.18
GF Value